Literature DB >> 2011110

Botulinum toxin therapy.

P J Savino1, M Maus.   

Abstract

Botulinum toxin therapy has emerged as a treatment modality for a variety of spastic- or contracture-related muscle diseases. Its safety has been proven for long-term use in the treatment of benign essential blepharospasm, hemifacial spasm, and certain types of strabismus. Recent approval from the Federal Drug Administration should make botulinum toxin available for use in a greater number of patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2011110

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  4 in total

1.  Magnetic resonance tomographic angiography in the investigation of hemifacial spasm.

Authors:  B Bernardi; R A Zimmerman; P J Savino; C Adler
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

2.  Embryonic stem cell-derived motoneurons provide a highly sensitive cell culture model for botulinum neurotoxin studies, with implications for high-throughput drug discovery.

Authors:  Erkan Kiris; Jonathan E Nuss; James C Burnett; Krishna P Kota; Dawn C Koh; Laura M Wanner; Edna Torres-Melendez; Rick Gussio; Lino Tessarollo; Sina Bavari
Journal:  Stem Cell Res       Date:  2011-01-19       Impact factor: 2.020

3.  Sensing the deadliest toxin: technologies for botulinum neurotoxin detection.

Authors:  Petr Capek; Tobin J Dickerson
Journal:  Toxins (Basel)       Date:  2010-01-07       Impact factor: 4.546

4.  Oro-mandibular dystonia.

Authors:  Yazad R Gandhi
Journal:  Natl J Maxillofac Surg       Date:  2010-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.